These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 21744995)
21. An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience. Morotti RA; Nicol KK; Parham DM; Teot LA; Moore J; Hayes J; Meyer W; Qualman SJ; Am J Surg Pathol; 2006 Aug; 30(8):962-8. PubMed ID: 16861966 [TBL] [Abstract][Full Text] [Related]
22. Rhabdomyosarcoma: value of myogenin expression analysis and molecular testing in diagnosing the alveolar subtype: an analysis of 109 paraffin-embedded specimens. Hostein I; Andraud-Fregeville M; Guillou L; Terrier-Lacombe MJ; Deminière C; Ranchère D; Lussan C; Longavenne E; Bui NB; Delattre O; Coindre JM Cancer; 2004 Dec; 101(12):2817-24. PubMed ID: 15536621 [TBL] [Abstract][Full Text] [Related]
23. Expression of insulin-like growth factor pathway proteins in rhabdomyosarcoma: IGF-2 expression is associated with translocation-negative tumors. Makawita S; Ho M; Durbin AD; Thorner PS; Malkin D; Somers GR Pediatr Dev Pathol; 2009; 12(2):127-35. PubMed ID: 18788888 [TBL] [Abstract][Full Text] [Related]
24. Detection of the MyoD1 transcript in rhabdomyosarcoma cell lines and tumor samples by reverse transcription polymerase chain reaction. Frascella E; Rosolen A Am J Pathol; 1998 Feb; 152(2):577-83. PubMed ID: 9466584 [TBL] [Abstract][Full Text] [Related]
25. Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma. Zibat A; Missiaglia E; Rosenberger A; Pritchard-Jones K; Shipley J; Hahn H; Fulda S Oncogene; 2010 Dec; 29(48):6323-30. PubMed ID: 20818440 [TBL] [Abstract][Full Text] [Related]
26. Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development. Tonin PN; Scrable H; Shimada H; Cavenee WK Cancer Res; 1991 Oct; 51(19):5100-6. PubMed ID: 1717137 [TBL] [Abstract][Full Text] [Related]
27. Identification of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma. Ahn EH; Mercado GE; Laé M; Ladanyi M Oncol Rep; 2013 Aug; 30(2):968-78. PubMed ID: 23733015 [TBL] [Abstract][Full Text] [Related]
28. Methylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas. Chen B; Dias P; Jenkins JJ; Savell VH; Parham DM Am J Pathol; 1998 Apr; 152(4):1071-9. PubMed ID: 9546368 [TBL] [Abstract][Full Text] [Related]
29. [Discovery of a new mutation in MYOD1 characterizes a subset of aggressive embryonal rhabdomyosarcoma partnering with mutations of the PI3K-AKT pathway]. Orbach D Bull Cancer; 2014 Sep; 101(9):776-7. PubMed ID: 25295632 [No Abstract] [Full Text] [Related]
30. MYOD1 as a prognostic indicator in rhabdomyosarcoma. Ahmed AA; Habeebu S; Farooqi MS; Gamis AS; Gonzalez E; Flatt T; Sherman A; Surrey L; Arnold MA; Conces M; Koo S; Dioufa N; Barr FG; Tsokos MG Pediatr Blood Cancer; 2021 Sep; 68(9):e29085. PubMed ID: 33913590 [TBL] [Abstract][Full Text] [Related]
31. Chemoradiotherapy-induced Cytodifferentiation in Bladder/Prostate Rhabdomyosarcoma With Genetic Downregulation of Myogenin and MyoD1 Gene Expression: A Case Study and Review of the Literature. Agard H; Clark C; Massanyi E; Steele M; McMahon D Urology; 2020 Mar; 137():173-177. PubMed ID: 31945380 [TBL] [Abstract][Full Text] [Related]
32. A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas. Gattenloehner S; Dockhorn-Dworniczak B; Leuschner I; Vincent A; Müller-Hermelink HK; Marx A J Mol Diagn; 1999 Nov; 1(1):23-31. PubMed ID: 11272905 [TBL] [Abstract][Full Text] [Related]
33. NELL1, whose high expression correlates with negative outcomes, has different methylation patterns in alveolar and embryonal rhabdomyosarcoma. Tombolan L; Poli E; Martini P; Zin A; Romualdi C; Bisogno G; Lanfranchi G Oncotarget; 2017 May; 8(20):33086-33099. PubMed ID: 28380437 [TBL] [Abstract][Full Text] [Related]
34. Classification of rhabdomyosarcoma and its molecular basis. Parham DM; Barr FG Adv Anat Pathol; 2013 Nov; 20(6):387-97. PubMed ID: 24113309 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of New Monoclonal Anti-MyoD1 (MX049) for the Diagnosis of Rhabdomyosarcoma: Comparison with 5.8A, EP212, Anti-Desmin, Anti-Myogenin, and Fluorescence He Y; Chen X; Yu X Ann Clin Lab Sci; 2020 May; 50(3):412-416. PubMed ID: 32581037 [TBL] [Abstract][Full Text] [Related]
36. Mixed embryonal/alveolar rhabdomyosarcoma of the prostate: report of a case with molecular genetic studies and literature review. Treetipsatit J; Kittikowit W; Zielenska M; Chaipipat M; Thorner PS; Shuangshoti S Pediatr Dev Pathol; 2009; 12(5):383-9. PubMed ID: 19175284 [TBL] [Abstract][Full Text] [Related]
37. Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma. Szuhai K; de Jong D; Leung WY; Fletcher CD; Hogendoorn PC J Pathol; 2014 Feb; 232(3):300-7. PubMed ID: 24272621 [TBL] [Abstract][Full Text] [Related]
38. The paternally imprinted DLK1-GTL2 locus is differentially methylated in embryonal and alveolar rhabdomyosarcomas. Schneider G; Bowser MJ; Shin DM; Barr FG; Ratajczak MZ Int J Oncol; 2014 Jan; 44(1):295-300. PubMed ID: 24173021 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of new monoclonal anti-MyoD1 and anti-myogenin antibodies for the diagnosis of rhabdomyosarcoma. Cui S; Hano H; Harada T; Takai S; Masui F; Ushigome S Pathol Int; 1999 Jan; 49(1):62-8. PubMed ID: 10227726 [TBL] [Abstract][Full Text] [Related]
40. Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma. Anderson J; Gordon A; McManus A; Shipley J; Pritchard-Jones K Neoplasia; 1999 Oct; 1(4):340-8. PubMed ID: 10935489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]